Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1

ConditionProstate Cancer (Adenocarcinoma)

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexMale

Age18+

SponsorSt Vincent's Hospital, Sydney

About this trial

This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment.

Eligibility criteria

Qualifiers

Men with high-risk BCR PCa but no ADT+/-ARPI experience.

Men with ADT+/-ARPI experience who have experienced breast-related side effects from this treatment.

Disqualifiers

None

Trial design

Treatments tested in this trial

Semi-structured Interview

Treatment groups

24 Participants

are divided into 1 treatment group

Sponsors and collaborators

St Vincent's Hospital, Sydney

Lead sponsor

University of Technology, Sydney

Collaborator

Source ClinicalTrials.gov